EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ZVRA: Zevra Therapeutics Inc

02 Dec 25 15:59
LAST:

8.165

CHANGE:
 0.17		OPEN:
8.430		HIGH:
8.525		ASK:
0.000		VOLUME:
732.5K
CHG(%):
2.04		PREV:
8.340		LOW:
8.160		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Dec 258.3808.5208.1608.1701.06M
01 Dec 258.4008.5908.2508.3401.22M
28 Nov 258.7108.7508.4108.430567.8K
26 Nov 258.4508.6508.3408.6001.08M
25 Nov 258.6508.7508.2808.4001.64M
24 Nov 258.8908.8908.5008.640903.5K
21 Nov 258.6708.8308.0118.6003.34M
20 Nov 259.7909.8809.0109.0501.02M
19 Nov 259.8709.8809.3909.680981.0K
18 Nov 259.1809.9509.0809.7001.53M

PROFILE

Name:Zevra Therapeutics Inc
About:Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 2 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase 1/2 clinical trial to treat narcolepsy. The company is also developing Celiprolol, a prodrug product candidate that is under Phase 3 clinical trial for the treatment of vascular Ehlers Danlos syndrome. In addition, it offers AZSTARYS, a once-daily treatment for attention deficit and hyperactivity disorder in patients aged six years and older; OLPRUVA to treat urea cycle disorders; and MIPLYFFA for the treatment of niemann pick disease type C, an ultra-rare neurodegenerative lysosomal storage disorder. The company has collaboration and license agreement with Commave Therapeutics SA to develop, manufacture and commercialize the company's product candidates containing SDX and d-methylphenidate; and license agreement with Acer and Relief Therapeutics, Inc. to develop and commercialize rights for OLPRUVA. The company was formerly known as KemPharm, Inc. and changed its name to Zevra Therapeutics, Inc. in February 2023. Zevra Therapeutics, Inc. was incorporated in 2006 and is headquartered in Celebration, Florida.
Sector:Healthcare
Industry:Biotechnology
Address:1180 Celebration Boulevard, Celebration, FL, United States, 34747
Website:https://zevra.com
CIK:0001434647
ISIN:US4884452065
FIGI:BBG0026ZG1F5
LEI:254900CU6T74V18Y1W18

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-4.48 
Forward P/E:-25.59 
PEG Ratio:0.01 
Price to Sales:9.03 
Price to Book:4.69 
Profit Margin:0.04 
Operating Margin:-0.48 
Return on Assets:-0.19 
Return on Equity:0.04 
EPS Ratio:-0.25 
Revenue:62.02M 
Shares:56.14M 
Market Cap:458.34M 

TECHNICAL INDICATORS

MA5:8.392.7%
MA10:8.767.3%
MA20:9.0310.6%
MA50:9.8020.0%
MA100:9.8921.2%
MA200:9.0911.3%
RSI14:31.36 
WPR14:-100.00 
MTM14:-1.23
ROC14:-0.13 
ATR:0.53 
Week High:8.757.2%
Week Low:8.160.1%
Month High:10.5629.3%
Month Low:8.0111.3%
Year High:13.1661.2%
Year Low:6.1931.9%
Volatility:16.33 

RECENT SPLITS

Date Ratio
28 Dec 20201-16